ReviewArchives of endocrinology and metabolism

Medullary thyroid carcinoma - Adverse events during systemic treatment: risk-benefit ratio.

Léa Maria Zanini Maciel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.